Alistair's Feed
Apr 28, 2014

AstraZeneca bid supports FTSE 100 despite ripples from Russian sanctions

LONDON, April 28 (Reuters) – AstraZeneca shares surged to
boost Britain’s top share index on Monday, after U.S. rival
Pfizer said it wanted to buy the drugmaker.

The FTSE 100 looked set to post a new 7-week closing
high, despite a volatile afternoon session as investors digested
new sanctions on Russia from the United States.

Apr 28, 2014

AstraZeneca keeps FTSE near seven-week highs

LONDON (Reuters) – AstraZeneca shares surged to keep Britain’s top share index close to seven-week highs on Monday, after U.S. rival Pfizer said it wanted to buy the drugmaker.

Pfizer confirmed on Monday it had approached AstraZeneca in January and said it had contacted the company again on April 26 seeking discussions about a takeover.

Apr 28, 2014

AstraZeneca bid confirmation keeps FTSE 100 near 7-week highs

LONDON, April 28 (Reuters) – AstraZeneca shares surged to
keep Britain’s top share index close to seven-week highs on
Monday, after U.S. rival Pfizer said it wanted to buy
the drugmaker.

Pfizer confirmed on Monday it had approached AstraZeneca in
January and said it had contacted the company again on April 26
seeking discussions about a takeover.

Apr 25, 2014

European shares slip as Ukraine crisis deepens

LONDON/PARIS, April 25 (Reuters) – German stocks led
European shares lower on Friday as new signs of violence in
Ukraine hit sentiment, although equities remained underpinned by
corporate takeover activity.

Ukrainian forces killed up to five pro-Moscow rebels on
Thursday, prompting Russia to launch army drills near the
border. In response, the United States said on Friday it will
press European allies to impose more sanctions if Russia steps
up action in Ukraine.

Apr 23, 2014

Earnings boost to help German shares overtake peripheral peers

LONDON, April 23 (Reuters) – German shares may overtake
their Italian and Spanish peers as Europe’s star performers this
quarter, boosted by better corporate earnings at a time when
expensive valuations are making investors more selective.

German companies are seen beating consensus predictions with
their first quarter earnings while numbers from firms in Italy
and Spain are set to fall short of expectations, according to
estimates from the most accurate analysts aggregated by Thomson
Reuters StarMine.

Apr 23, 2014

Ericsson leads European shares lower after earnings miss

LONDON, April 23 (Reuters) – European shares fell on
Wednesday, retracing some of the previous session’s strong gains
as investors responded to weak earnings from Ericsson and mixed
data out of the euro zone.

Shares in the Swedish mobile telecom equipment maker
fell 4.9 percent, trimming the most points off of the
FTSEurofirst 300, after missing first-quarter sales and
profit forecasts on weak trading in North America.

Apr 23, 2014
Apr 23, 2014

French blue-chips lead European shares lower after euro zone PMIs

LONDON, April 23 (Reuters) – French blue-chip shares
underperformed their German counterparts on Wednesday after
survey data showed that the recovery in France is still weaker
than the euro zone’s biggest economy.

France’s CAC 40 index fell 0.3 percent,
underperforming a 0.2 percent drop on the pan-European
FTSEurofirst 300, after purchasing managers index (PMI)
data for the country showed waning momentum in its fragile
economic recovery.

Apr 22, 2014

M&A activity in pharmaceuticals pushes FTSE higher

LONDON (Reuters) – Merger and acquisition activity among drug companies drove Britain’s top share index to a two-week high on Tuesday, putting it within sight of its peak for 2014.

Drugmaker AstraZeneca surged 6.7 percent, with trading volumes in the stock over twice its 90-day average, after the Sunday Times newspaper reported a 60 billion-pound approach from U.S. peer Pfizer.

Apr 17, 2014

European shares fall as strong euro, China weakness hits earnings

LONDON, April 17 (Reuters) – European shares edged lower on
Thursday, weighed down by companies reporting earnings that were
knocked by currency effects and weak demand from China,
confirming a poor start to the earnings season in Europe.

Trade was subdued, with investors unwilling to place strong
bets on moves in either direction before a four-day weekend for
European markets.

    • About Alistair

      "Alistair Smout is working on the Investment and Emerging Markets for Reuters Europe over the summer. He specialises in Africa and Europe."
    • More from Alistair

    • Follow Alistair